MALDI TOF imaging mass spectrometry in clinical pathology: A valuable tool for cancer diagnostics (Review)
- Authors:
- Jörg Kriegsmann
- Mark Kriegsmann
- Rita Casadonte
-
Affiliations: MVZ for Histology, Cytology and Molecular Diagnostics, Trier, Germany, Institute for Pathology, University of Heidelberg, Heidelberg, Germany, Proteopath GmbH, Trier, Germany - Published online on: December 4, 2014 https://doi.org/10.3892/ijo.2014.2788
- Pages: 893-906
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
|
Patel R: MALDI-TOF mass spectrometry: transformative proteomics for clinical microbiology. Clin Chem. 59:340–342. 2013. View Article : Google Scholar | |
|
Clark AE, Kaleta EJ, Arora A and Wolk DM: Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin Microbiol Rev. 26:547–603. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Moore JL, Caprioli RM and Skaar EP: Advanced mass spectrometry technologies for the study of microbial pathogenesis. Curr Opin Microbiol. 19C:45–51. 2014. View Article : Google Scholar | |
|
Kueger S, Steinhauser D, Willmitzer L and Giavalisco P: High-resolution plant metabolomics: from mass spectral features to metabolites and from whole-cell analysis to subcellular metabolite distributions. Plant J. 70:39–50. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Schoenian I, Spiteller M, Ghaste M, Wirth R, Herz H and Spiteller D: Chemical basis of the synergism and antagonism in microbial communities in the nests of leaf-cutting ants. Proc Natl Acad Sci USA. 108:1955–1960. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chaurand P, Cornett DS, Angel PM and Caprioli RM: From whole-body sections down to cellular level, multiscale imaging of phospholipids by MALDI mass spectrometry. Mol Cell Proteomics. 10:O110.004259. 2011. View Article : Google Scholar : | |
|
Trim PJ, Henson CM, Avery JL, et al: Matrix-assisted laser desorption/ionization-ion mobility separation-mass spectrometry imaging of vinblastine in whole body tissue sections. Anal Chem. 80:8628–8634. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Reyzer ML, Chaurand P, Angel PM and Caprioli RM: Direct molecular analysis of whole-body animal tissue sections by MALDI imaging mass spectrometry. Methods Mol Biol. 656:285–301. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Remmerbach TW, Maurer K, Janke S, et al: Oral brush biopsy analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry profiling: a pilot study. Oral Oncol. 47:278–281. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Schwamborn K, Krieg RC, Uhlig S, Ikenberg H and Wellmann A: MALDI imaging as a specific diagnostic tool for routine cervical cytology specimens. Int J Mol Med. 27:417–421. 2011. | |
|
Kriegsmann M, Seeley EH, Schwarting A, et al: MALDI MS imaging as a powerful tool for investigating synovial tissue. Scand J Rheumatol. 41:305–309. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Seeley EH and Caprioli RM: MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. Trends Biotechnol. 29:136–143. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Meding S, Nitsche U, Balluff B, et al: Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. J Proteome Res. 11:1996–2003. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Nipp M, Elsner M, Balluff B, et al: S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging. J Mol Med. 90:163–174. 2012. View Article : Google Scholar | |
|
Steurer S, Seddiqi AS, Singer JM, et al: MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype. Anticancer Res. 34:2255–2261. 2014.PubMed/NCBI | |
|
Morita Y, Ikegami K, Goto-Inoue N, et al: Imaging mass spectrometry of gastric carcinoma in formalin-fixed paraffin-embedded tissue microarray. Cancer Sci. 101:267–273. 2010. View Article : Google Scholar | |
|
Gode D and Volmer DA: Lipid imaging by mass spectrometry - a review. Analyst. 138:1289–1315. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Horn PJ and Chapman KD: Lipidomics in situ: insights into plant lipid metabolism from high resolution spatial maps of metabolites. Prog Lipid Res. 54:32–52. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sparvero LJ, Amoscato AA, Dixon CE, et al: Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and expectations. Chem Phys Lipids. 165:545–562. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Harvey DJ: Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2009–2010. Mass Spectrom Rev. May 26–2014. View Article : Google Scholar : (Epub ahead of print). | |
|
Reyzer ML, Hsieh Y, Ng K, Korfmacher WA and Caprioli RM: Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom. 38:1081–1092. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Norris JL and Caprioli RM: Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. Chem Rev. 113:2309–2342. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Groseclose MR and Castellino S: A mimetic tissue model for the quantification of drug distributions by MALDI imaging mass spectrometry. Anal Chem. 85:10099–10106. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Honisch C, Chen Y, Mortimer C, et al: Automated comparative sequence analysis by base-specific cleavage and mass spectrometry for nucleic acid-based microbial typing. Proc Natl Acad Sci USA. 104:10649–10654. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Okamoto I, Sakai K, Morita S, et al: Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study. Oncotarget. 5:2293–2304. 2014.PubMed/NCBI | |
|
Castellino S, Groseclose MR and Wagner D: MALDI imaging mass spectrometry: bridging biology and chemistry in drug development. Bioanalysis. 3:2427–2441. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Rompp A, Guenther S, Takats Z and Spengler B: Mass spectrometry imaging with high resolution in mass and space (HR(2) MSI) for reliable investigation of drug compound distributions on the cellular level. Anal Bioanal Chem. 401:65–73. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Caprioli RM, Farmer TB and Gile J: Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem. 69:4751–4760. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Schone C, Hofler H and Walch A: MALDI imaging mass spectrometry in cancer research: combining proteomic profiling and histological evaluation. Clin Biochem. 46:539–545. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gessel MM, Norris JL and Caprioli RM: MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discovery. J Proteomics. 107:71–82. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Thomas A, Lenglet S, Chaurand P, et al: Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics. Thromb Haemost. 106:20–33. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
McClure RA, Chumbley CW, Reyzer ML, et al: Identification of promethazine as an amyloid-binding molecule using a fluorescence high-throughput assay and MALDI imaging mass spectrometry. Neuroimage Clin. 2:620–629. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kriegsmann M, Casadonte R, Randau T, et al: MALDI imaging of predictive ferritin, fibrinogen and proteases in haemophilic arthropathy. Haemophilia. 20:446–453. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Seeley EH and Caprioli RM: Molecular imaging of proteins in tissues by mass spectrometry. Proc Natl Acad Sci USA. 105:18126–18131. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Seeley EH, Washington MK, Caprioli RM and M’Koma AE: Proteomic patterns of colonic mucosal tissues delineate Crohn’s colitis and ulcerative colitis. Proteomics Clin Appl. 7:541–549. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lalowski M, Magni F, Mainini V, et al: Imaging mass spectrometry: a new tool for kidney disease investigations. Nephrol Dial Transplant. 28:1648–1656. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Mainini V, Pagni F, Ferrario F, et al: MALDI imaging mass spectrometry in glomerulonephritis: feasibility study. Histopathology. 64:901–906. 2014. View Article : Google Scholar | |
|
Xu BJ, Shyr Y, Liang X, et al: Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol. 16:2967–2975. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lagarrigue M, Becker M, Lavigne R, et al: Revisiting rat spermatogenesis with MALDI imaging at 20-microm resolution. Mol Cell Proteomic. 10:M110.005991. 2011. View Article : Google Scholar | |
|
Willems SM, van Remoortere A, van Zeijl R, Deelder AM, McDonnell LA and Hogendoorn PC: Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity. J Pathol. 222:400–409. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Schwamborn K, Krieg RC, Reska M, Jakse G, Knuechel R and Wellmann A: Identifying prostate carcinoma by MALDI-Imaging. Int J Mol Med. 20:155–159. 2007.PubMed/NCBI | |
|
Rodrigo MA, Zitka O, Krizkova S, Moulick A, Adam V and Kizek R: MALDI-TOF MS as evolving cancer diagnostic tool: a review. J Pharm Biomed Anal. 95:245–255. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Rahman SM, Gonzalez AL, Li M, et al: Lung cancer diagnosis from proteomic analysis of preinvasive lesions. Cancer Res. 71:3009–3017. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Oppenheimer SR, Mi D, Sanders ME and Caprioli RM: Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. J Proteome Res. 9:2182–2190. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Jones EE, Powers TW, Neely BA, et al: MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma. Proteomics. 14:924–935. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Angel PM and Caprioli RM: Matrix-assisted laser desorption ionization imaging mass spectrometry: in situ molecular mapping. Biochemistry. 52:3818–3828. 2013. View Article : Google Scholar | |
|
Boggio KJ, Obasuyi E, Sugino K, Nelson SB, Agar NY and Agar JN: Recent advances in single-cell MALDI mass spectrometry imaging and potential clinical impact. Expert Rev Proteomics. 8:591–604. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Eriksson C, Masaki N, Yao I, Hayasaka T and Setou M: MALDI imaging mass spectrometry-A mini review of methods and recent developments. Mass Spectrom. 2:S00222013. View Article : Google Scholar | |
|
Dreisewerd K: Recent methodological advances in MALDI mass spectrometry. Anal Bioanal Chem. 406:2261–2278. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Fujimura Y and Miura D: MALDI mass spectrometry imaging for visualizing in situ metabolism of endogenous metabolites and dietary phytochemicals. Metabolites. 4:319–346. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gorzolka K and Walch A: MALDI mass spectrometry imaging of formalin-fixed paraffin-embedded tissues in clinical research. Histol Histopathol. 29:1365–1376. 2014.PubMed/NCBI | |
|
Schwamborn K and Caprioli RM: Molecular imaging by mass spectrometry: looking beyond classical histology. Nat Rev Cancer. 10:639–646. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Chaurand P: Imaging mass spectrometry of thin tissue sections: a decade of collective efforts. J Proteomics. 75:4883–4892. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Rompp A and Spengler B: Mass spectrometry imaging with high resolution in mass and space. Histochem Cell Biol. 139:759–783. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Goodwin RJ: Sample preparation for mass spectrometry imaging: small mistakes can lead to big consequences. J Proteomics. 75:4893–4911. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kaletas BK, van der Wiel IM, Stauber J, et al: Sample preparation issues for tissue imaging by imaging MS. Proteomics. 9:2622–2633. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Stoeckli M, Chaurand P, Hallahan DE and Caprioli RM: Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med. 7:493–496. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Cornett DS, Mobley JA, Dias EC, et al: A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol Cell Proteomics. 5:1975–1983. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Seeley EH, Schwamborn K and Caprioli RM: Imaging of intact tissue sections: moving beyond the microscope. J Biol Chem. 286:25459–25466. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zavalin A, Yang J and Caprioli R: Laser beam filtration for high spatial resolution MALDI imaging mass spectrometry. J Am Soc Mass Spectrom. 24:1153–1156. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Caprioli RM: Imaging mass spectrometry: molecular microscopy for enabling a new age of discovery. Proteomics. 14:807–809. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Norris JL, Cornett DS, Mobley JA, et al: Processing MALDI Mass Spectra to improve mass spectral direct tissue analysis. Int J Mass Spectrom. 260:212–221. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Djidja MC, Claude E, Snel MF, et al: Novel molecular tumour classification using MALDI-mass spectrometry imaging of tissue microarray. Anal Bioanal Chem. 397:587–601. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Andersson M, Groseclose MR, Deutch AY and Caprioli RM: Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction. Nat Methods. 5:101–108. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Crecelius AC, Cornett DS, Caprioli RM, Williams B, Dawant BM and Bodenheimer B: Three-dimensional visualization of protein expression in mouse brain structures using imaging mass spectrometry. J Am Soc Mass Spectrom. 16:1093–1099. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Pagni F, Mainini V, Garancini M, et al: Proteomics for the diagnosis of thyroid lesions: preliminary report. Cytopathology. Jul 20–2014. View Article : Google Scholar : (Epub ahead of print). | |
|
Groseclose MR, Massion PP, Chaurand P and Caprioli RM: High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics. 8:3715–3724. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Gancberg D, Jarvinen T, di Leo A, et al: Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testing. Breast Cancer Res Treat. 74:113–120. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Thaysen-Andersen M, Wilkinson BL, Payne RJ and Packer NH: Site-specific characterisation of densely O-glycosylated mucin-type peptides using electron transfer dissociation ESI-MS/MS. Electrophoresis. 32:3536–3545. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ronci M, Sharma S, Chataway T, et al: MALDI-MS-imaging of whole human lens capsule. J Proteome Res. 10:3522–3529. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bona A, Papai Z, Maasz G, et al: Mass spectrometric identification of ancient proteins as potential molecular biomarkers for a 2000-year-old osteogenic sarcoma. PLoS One. 9:e872152014. View Article : Google Scholar : PubMed/NCBI | |
|
Morgan TM, Seeley EH, Fadare O, Caprioli RM and Clark PE: Imaging the clear cell renal cell carcinoma proteome. J Urol. 189:1097–1103. 2013. View Article : Google Scholar : | |
|
Dekker TJ, Balluff BD, Jones EA, et al: Multicenter Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma. J Proteome Res. May 2–2014.(Epub ahead of print). View Article : Google Scholar | |
|
Rauser S, Marquardt C, Balluff B, et al: Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. J Proteome Res. 9:1854–1863. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Le Faouder J, Laouirem S, Chapelle M, et al: Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis. J Proteome Res. 10:3755–3765. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Yanagisawa K, Shyr Y, Xu BJ, et al: Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet. 362:433–439. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Gruner BM, Hahne H, Mazur PK, et al: MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer. PLoS One. 7:e394242012. View Article : Google Scholar : PubMed/NCBI | |
|
Balluff B, Rauser S, Meding S, et al: MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. Am J Pathol. 179:2720–2729. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kim HK, Reyzer ML, Choi IJ, et al: Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. J Proteome Res. 9:4123–4130. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Casadonte R and Caprioli RM: Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry. Nat Protoc. 6:1695–1709. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Djidja MC, Chang J, Hadjiprocopis A, et al: Identification of hypoxia-regulated proteins using MALDI-mass spectrometry imaging combined with quantitative proteomics. J Proteome Res. 13:2297–2313. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Steurer S, Borkowski C, Odinga S, et al: MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays. Int J Cancer. 133:920–928. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Casadonte R, Kriegsmann M, Zweynert F, et al: Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin-fixed paraffin-embedded tissues. Proteomics. 14:956–964. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ikeda K, Monden T, Kanoh T, et al: Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections. J Histochem Cytochem. 46:397–403. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Becker KF, Schott C, Hipp S, et al: Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol. 211:370–378. 2007. View Article : Google Scholar | |
|
Chung JY, Lee SJ, Kris Y, Braunschweig T, Traicoff JL and Hewitt SM: A well-based reverse-phase protein array applicable to extracts from formalin-fixed paraffin-embedded tissue. Proteomics Clin Appl. 2:1539–1547. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Nirmalan NJ, Harnden P, Selby PJ and Banks RE: Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting. J Pathol. 217:497–506. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Crockett DK, Lin Z, Vaughn CP, Lim MS and Elenitoba-Johnson KS: Identification of proteins from formalin-fixed paraffin-embedded cells by LC-MS/MS. Lab Invest. 85:1405–1415. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Hood BL, Darfler MM, Guiel TG, et al: Proteomic analysis of formalin-fixed prostate cancer tissue. Mol Cell Proteomics. 4:1741–1753. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Palmer-Toy DE, Krastins B, Sarracino DA, Nadol JB Jr and Merchant SN: Efficient method for the proteomic analysis of fixed and embedded tissues. J Proteome Res. 4:2404–2411. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Becker KF, Berg D, Malinowsky K, et al: Update on protein analysis of fixed tissues. Pathologe. 31(Suppl 2): 263–267. 2010. View Article : Google Scholar | |
|
Shi SR, Liu C, Balgley BM, Lee C and Taylor CR: Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry. J Histochem Cytochem. 54:739–743. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
McDonnell LA, Walch A, Stoeckli M and Corthals GL: MSiMass list: a public database of identifications for protein MALDI MS imaging. J Proteome Res. 13:1138–1142. 2014. View Article : Google Scholar | |
|
Maier SK, Hahne H, Gholami AM, et al: Comprehensive identification of proteins from MALDI imaging. Mol Cell Proteomics. 12:2901–2910. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Deininger SO, Ebert MP, Futterer A, Gerhard M and Rocken C: MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. J Proteome Res. 7:5230–5236. 2008. View Article : Google Scholar | |
|
Caprioli RM: Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy. Cancer Res. 65:10642–10645. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Chaurand P, Sanders ME, Jensen RA and Caprioli RM: Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am J Pathol. 165:1057–1068. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kang S, Shim HS, Lee JS, et al: Molecular proteomics imaging of tumor interfaces by mass spectrometry. J Proteome Res. 9:1157–1164. 2010. View Article : Google Scholar | |
|
Han EC, Lee YS, Liao WS, Liu YC, Liao HY and Jeng LB: Direct tissue analysis by MALDI-TOF mass spectrometry in human hepatocellular carcinoma. Clin Chim Acta. 412:230–239. 2011. View Article : Google Scholar | |
|
Eberlin LS, Norton I, Orringer D, et al: Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors. Proc Natl Acad Sci USA. 110:1611–1616. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Schwartz SA, Weil RJ, Thompson RC, et al: Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res. 65:7674–7681. 2005.PubMed/NCBI | |
|
Lemaire R, Menguellet SA, Stauber J, et al: Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. J Proteome Res. 6:4127–4134. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Elsner M, Rauser S, Maier S, et al: MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett’s adenocarcinoma. J Proteomics. 75:4693–4704. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Flatley B, Malone P and Cramer R: MALDI mass spectrometry in prostate cancer biomarker discovery. Biochim Biophys Acta. 1844:940–949. 2014. View Article : Google Scholar | |
|
Hardesty WM, Kelley MC, Mi D, Low RL and Caprioli RM: Protein signatures for survival and recurrence in metastatic melanoma. J Proteomics. 74:1002–1014. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Oezdemir RF, Gaisa NT, Lindemann-Docter K, et al: Proteomic tissue profiling for the improvement of grading of noninvasive papillary urothelial neoplasia. Clin Biochem. 45:7–11. 2012. View Article : Google Scholar | |
|
Chaurand P, Schwartz SA, Billheimer D, Xu BJ, Crecelius A and Caprioli RM: Integrating histology and imaging mass spectrometry. Anal Chem. 76:1145–1155. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Schwartz SA, Weil RJ, Johnson MD, Toms SA and Caprioli RM: Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin Cancer Res. 10:981–987. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Choi JH, Shin NR, Moon HJ, et al: Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma. Histol Histopathol. 27:1439–1448. 2012.PubMed/NCBI | |
|
Reyzer ML, Caldwell RL, Dugger TC, et al: Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res. 64:9093–9100. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Vegvari A, Fehniger TE, Rezeli M, et al: Experimental models to study drug distributions in tissue using MALDI mass spectrometry imaging. J Proteome Res. 12:5626–5633. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sugihara Y, Vegvari A, Welinder C, et al: A new look at drugs targeting malignant melanoma - an application for mass spectrometry imaging. Proteomics. 14:1963–1970. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bianga J, Bouslimani A, Bec N, et al: Complementarity of MALDI and LA ICP mass spectrometry for platinum anticancer imaging in human tumor. Metallomics. 6:1382–1386. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Ide JL, Norton I, et al: Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging. Sci Rep. 3:28592013.PubMed/NCBI | |
|
Buck A and Walch A: In situ drug and metabolite analyzes in biological and clinical research by MALDI MS imaging. Bioanalysis. 6:1241–1253. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Jirasko R, Holcapek M, Kunes M and Svatos A: Distribution study of atorvastatin and its metabolites in rat tissues using combined information from UHPLC/MS and MALDI-Orbitrap-MS imaging. Anal Bioanal Chem. 406:4601–4610. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Huber K, Aichler M, Sun N, et al: A rapid ex vivo tissue model for optimising drug detection and ionisation in MALDI imaging studies. Histochem Cell Biol. 142:361–371. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yasunaga M, Furuta M, Ogata K, et al: The significance of microscopic mass spectrometry with high resolution in the visualisation of drug distribution. Sci Rep. 3:30502013. View Article : Google Scholar : PubMed/NCBI | |
|
Salphati L, Shahidi-Latham S, Quiason C, et al: Distribution of the phosphatidylinositol 3-kinase inhibitors Pictilisib (GDC-0941) and GNE-317 in U87 and GS2 intracranial glioblastoma models-assessment by matrix-assisted laser desorption ionization imaging. Drug Metab Dispos. 42:1110–1116. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zecchi R, Trevisani M, Pittelli M, et al: Impact of drug administration route on drug delivery and distribution into the lung: an imaging mass spectrometry approach. Eur J Mass Spectrom. 19:475–482. 2013. View Article : Google Scholar | |
|
Bouamrani A, Ternier J, Ratel D, et al: Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics. Clin Chem. 52:2103–2106. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Agar NY, Malcolm JG, Mohan V, et al: Imaging of meningioma progression by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Anal Chem. 82:2621–2625. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ronci M, Bonanno E, Colantoni A, et al: Protein unlocking procedures of formalin-fixed paraffin-embedded tissues: application to MALDI-TOF imaging MS investigations. Proteomics. 8:3702–3714. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Qin XJ and Ling BX: Proteomic studies in breast cancer (Review). Oncol Lett. 3:735–743. 2012.PubMed/NCBI | |
|
Seeley EH and Caprioli RM: Imaging mass spectrometry: towards clinical diagnostics. Proteomics Clin Appl. 2:1435–1443. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Walch A, Rauser S, Deininger SO and Hofler H: MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology. Histochem Cell Biol. 130:421–434. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Amstalden van Hove ER, Blackwell TR, Klinkert I, Eijkel GB, Heeren RM and Glunde K: Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models. Cancer Res. 70:9012–9021. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Chughtai K, Jiang L, Greenwood TR, Glunde K and Heeren RM: Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB-231 breast tumor models. J Lipid Res. 54:333–344. 2013. View Article : Google Scholar : | |
|
Patel SA, Barnes A, Loftus N, et al: Imaging mass spectrometry using chemical inkjet printing reveals differential protein expression in human oral squamous cell carcinoma. Analyst. 134:301–307. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Thomas A, Patterson NH, Marcinkiewicz MM, Lazaris A, Metrakos P and Chaurand P: Histology-driven data mining of lipid signatures from multiple imaging mass spectrometry analyses: application to human colorectal cancer liver metastasis biopsies. Anal Chem. 85:2860–2866. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Rahman SM, Shyr Y, Yildiz PB, et al: Proteomic patterns of preinvasive bronchial lesions. Am J Respir Crit Care Med. 172:1556–1562. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lee GK, Lee HS, Park YS, et al: Lipid MALDI profile classifies non-small cell lung cancers according to the histologic type. Lung Cancer. 76:197–203. 2012. View Article : Google Scholar | |
|
Hassanein M, Rahman JS, Chaurand P and Massion PP: Advances in proteomic strategies toward the early detection of lung cancer. Proc Am Thorac Soc. 8:183–188. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Schwamborn K, Krieg RC, Jirak P, et al: Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma. J Cancer Res Clin Oncol. 136:1651–1655. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lazova R, Seeley EH, Keenan M, Gueorguieva R and Caprioli RM: Imaging mass spectrometry - a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas. Am J Dermatopathol. 34:82–90. 2012. View Article : Google Scholar : | |
|
Min KW, Bang JY, Kim KP, et al: Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins. J Korean Med Sci. 29:934–940. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Junker H, Venz S, Zimmermann U, Thiele A, Scharf C and Walther R: Stage-related alterations in renal cell carcinoma-comprehensive quantitative analysis by 2D-DIGE and protein network analysis. PLoS One. 6:e218672011. View Article : Google Scholar | |
|
Chinello C, Gianazza E, Zoppis I, et al: Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on ClinProt technique. Urology. 75:842–847. 2010. View Article : Google Scholar | |
|
Axt J, Murphy AJ, Seeley EH, et al: Race disparities in Wilms tumor incidence and biology. J Surg Res. 170:112–119. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Steurer S, Singer JM, Rink M, et al: MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays. Urol Oncol. Aug 14–2014. View Article : Google Scholar : (Epub ahead of print). | |
|
Liu Y, Chen Y, Momin A, et al: Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry. Mol Cancer. 9:1862010. View Article : Google Scholar : PubMed/NCBI | |
|
Meding S, Martin K, Gustafsson OJ, et al: Tryptic peptide reference data sets for MALDI imaging mass spectrometry on formalin-fixed ovarian cancer tissues. J Proteome Res. 12:308–315. 2013. View Article : Google Scholar | |
|
Cazares LH, Troyer D, Mendrinos S, et al: Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Clin Cancer Res. 15:5541–5551. 2009. View Article : Google Scholar : PubMed/NCBI |
